These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 12894872)

  • 21. Reconstitution of cytomegalovirus specific T cells after pediatric allogeneic stem cell transplantation: results from a pilot study using a multi-allele CMV tetramer group.
    Koehl U; Dirkwinkel E; Koenig M; Erben S; Soerensen J; Bader P; Doerr HW; Preiser W; Weissinger E; Klingebiel T; Martin H; Lehrnbecher T
    Klin Padiatr; 2008; 220(6):348-52. PubMed ID: 18949669
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of cytomegalovirus viremia on subclinical rejection or interstitial fibrosis and tubular atrophy in protocol biopsy at 3 months in renal allograft recipients managed by preemptive therapy or antiviral prophylaxis.
    Reischig T; Jindra P; Hes O; Bouda M; Kormunda S; Treska V
    Transplantation; 2009 Feb; 87(3):436-44. PubMed ID: 19202451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiviral CD8 T cells in the control of primary human cytomegalovirus infection in early childhood.
    Chen SF; Tu WW; Sharp MA; Tongson EC; He XS; Greenberg HB; Holmes TH; Wang Z; Kemble G; Manganello AM; Adler SP; Dekker CL; Lewis DB; Arvin AM
    J Infect Dis; 2004 May; 189(9):1619-27. PubMed ID: 15116298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD8+ T-cell maturation following lung transplantation: the differential impact of CMV and acute rejection.
    Westall GP; Brooks AG; Kotsimbos T
    Transpl Immunol; 2007 Nov; 18(2):186-92. PubMed ID: 18005866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection.
    Wang Z; La Rosa C; Lacey SF; Maas R; Mekhoubad S; Britt WJ; Diamond DJ
    J Clin Virol; 2006 Mar; 35(3):324-31. PubMed ID: 16388983
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute rejection episodes in pediatric renal transplant recipients with cytomegalovirus infection.
    Kranz B; Vester U; Wingen AM; Nadalin S; Paul A; Broelsch CE; Hoyer PF
    Pediatr Transplant; 2008 Jun; 12(4):474-8. PubMed ID: 18466436
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissection of the CMV specific T-cell response is required for optimized cardiac transplant monitoring.
    Kirchner A; Hoffmeister B; Cherepnev-G G; Fuhrmann S; Streitz M; Lachmann R; Bunde T; Meij P; Schönemann C; Hetzer R; Lehmkuhl HB; Volkmer-Engert R; Volk HD; Gratama JW; Kern F
    J Med Virol; 2008 Sep; 80(9):1604-14. PubMed ID: 18649330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytomegalovirus: occurrence, severity, and effect on graft survival in simultaneous pancreas-kidney transplantation.
    Ricart MJ; Malaise J; Moreno A; Crespo M; Fernández-Cruz L;
    Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii25-ii32, ii62. PubMed ID: 15814546
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cytomegalovirus infection in lung transplantation; current status, detection, prophylactic treatment].
    Aoe M; Tao H; Yamane M; Toyooka S; Sano Y; Okazaki M; Date H
    Kyobu Geka; 2007 Oct; 60(11):988-92. PubMed ID: 17926902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A lower incidence of cytomegalovirus infection in de novo heart transplant recipients randomized to everolimus.
    Hill JA; Hummel M; Starling RC; Kobashigawa JA; Perrone SV; Arizón JM; Simonsen S; Abeywickrama KH; Bara C
    Transplantation; 2007 Dec; 84(11):1436-42. PubMed ID: 18091519
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk for cytomegalovirus infection following reduced intensity allogeneic stem cell transplantation.
    Nachbaur D; Larcher C; Kircher B; Eibl G; Nussbaumer W; Gunsilius E; Haun M; Grünewald K; Gastl G
    Ann Hematol; 2003 Oct; 82(10):621-7. PubMed ID: 12920570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytomegalovirus infection in renal transplant recipients.
    Carstens J; Andersen HK; Spencer E; Madsen M
    Transpl Infect Dis; 2006 Dec; 8(4):203-12. PubMed ID: 17116133
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analyzing T-cell responses to cytomegalovirus by cytokine flow cytometry.
    Maecker HT; Maino VC
    Hum Immunol; 2004 May; 65(5):493-9. PubMed ID: 15172449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of cytomegalovirus-specific T-cell reconstitution in patients after various allogeneic haematopoietic stem cell transplantation using interferon-gamma-enzyme-linked immunospot and human leucocyte antigen tetramer assays with an immunodominant T-cell epitope.
    Ohnishi M; Sakurai T; Heike Y; Yamazaki R; Kanda Y; Takaue Y; Mizoguchi H; Kawakami Y
    Br J Haematol; 2005 Nov; 131(4):472-9. PubMed ID: 16281937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prognostic effect of lymphocyte subgroup CD4+ and CD8+ cells in peripheral blood in renal transplant patients with cytomegalovirus viremia.
    Chen JS; Li LS; Cheng DR; Ji SM; Sun QQ; Cheng Z; Wen JQ; Sha GZ; Liu ZH
    Transplant Proc; 2009 Jun; 41(5):1639-42. PubMed ID: 19545698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.
    Stone SF; Price P; French MA
    J Antimicrob Chemother; 2006 Apr; 57(4):585-8. PubMed ID: 16504998
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human cytomegalovirus-specific CD4+ and CD8+ T cell responses in primary infection of the immunocompetent and the immunocompromised host.
    Lilleri D; Zelini P; Fornara C; Comolli G; Revello MG; Gerna G
    Clin Immunol; 2009 Jun; 131(3):395-403. PubMed ID: 19268633
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multimer staining of cytomegalovirus phosphoprotein 65-specific T cells for diagnosis and therapeutic purposes: a comparative study.
    Yao J; Bechter C; Wiesneth M; Härter G; Götz M; Germeroth L; Guillaume P; Hasan F; von Harsdorf S; Mertens T; Michel D; Döhner H; Bunjes D; Schmitt M; Schmitt A
    Clin Infect Dis; 2008 May; 46(10):e96-105. PubMed ID: 18419478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Deficiency of cytomegalovirus (CMV)-specific CD8+ T cells in patients presenting with late-onset CMV disease several years after transplantation.
    Cummins NW; Deziel PJ; Abraham RS; Razonable RR
    Transpl Infect Dis; 2009 Feb; 11(1):20-7. PubMed ID: 18811629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Reducing the risk of viral infection in renal transplantation.
    Tibbles LA
    Transplant Proc; 2008 Dec; 40(10 Suppl):S48-51. PubMed ID: 19100908
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.